Skip to main content
OpenTrials

Clinical trial condition

Clear-cell metastatic renal cell carcinoma

Explore clinical trials studying Clear-cell metastatic renal cell carcinoma. Study availability and eligibility vary by location and protocol.

54 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Clear-cell metastatic renal cell carcinoma trial results

Active, not recruiting

Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

NCT04696731

Conditions
Adenocarcinoma, Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Carcinoma, +15 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View Trial Details
Active, not recruiting

AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)

NCT06245915

Conditions
Adenocarcinoma, Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Carcinoma, +19 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Iowa and Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View Trial Details
Completed

A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy

NCT01693822

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Royal Surrey County Hospital Guildford, Surrey, United Kingdom
  • Royal Marsden Hospital - Sutton London, Sutton, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
  • Western General Hospital Edinburgh, United Kingdom
View Trial Details

Related conditions